U266B1

U266B1

收藏
  • 询价
  • 2025年08月28日
    avatar
    14金牌会员
  • 企业认证

    • 详细信息
    • 询价记录
    • 技术资料
    • 生长状态

      悬浮生长

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 库存

      大量

    • 细胞类型

      B淋巴细胞

    • 器官来源

      外周血

    • 相关疾病

      其他疾病

    • ATCC Number

      TIB-196™

    • 年限

      53 years adult

    • 免疫类型

      IgE; lambda light chain

    • 细胞形态

      淋巴样

    • 运输方式

      冻存运输

    Designations: U266B1 [U266]
    Depositors:  NK Nilsson
    Isotype: IgE; lambda light chain
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Homo sapiens
    Morphology: lymphoblast

    Source: Organ: peripheral blood
    Disease: myeloma; plasmacytoma
    Cell Type: B lymphocyte;
    Cellular Products: immunoglobulin; monoclonal antibody; interleukin 6 (interleukin-6, IL-6)
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications: transfection host
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 12,13
    D13S317: 12
    D16S539: 10
    D5S818: 11,12
    D7S820: 11,12
    THO1: 5,7
    TPOX: 8
    vWA: 17
    Age: 53 years adult
    Gender: male
    Comments: U266 cells have been reported to produce human IL-6.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.
    Subculturing: Medium Renewal: Every 2 to 3 days
    Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 x 10 exp5 cells/ml and maintain between 1 x 10 exp5 and 1 x 10 exp6 cells/ml.
    Preservation: culture medium 95%; DMSO, 5%
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    References: 1180: Nilsson K, et al. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7: 477-489, 1970. PubMed: 4097745
    22377: Kawano M, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988. PubMed: 3258060
    32396: Kolanus W, et al. alphaLbeta2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1 a cytoplasmic regulatory molecule. Cell 86: 233-242, 1996. PubMed: 8706128

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥680
    上海联迈生物工程有限公司
    2025年10月27日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月11日询价
    询价
    上海复祥生物科技有限公司
    2025年11月24日询价
    ¥800
    上海沪震实业有限公司
    2025年07月12日询价
    ¥800
    上海康朗生物科技有限公司
    2025年07月12日询价
    U266B1
    询价